黑料网

Scientists argue the criteria we use for diagnosing autism may need revision

Without clear and effective biological tests for autism based on genes, brain or blood measurements, diagnosis today still largely depends on clinical assessment. The standard way of doing this is by observing how the individual fits the criteria for autism listed in gold standard manuals like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).

Scientists argue the criteria we use for diagnosing autism may need revision

Without clear and effective biological tests for autism based on genes, brain or blood measurements, diagnosis today still largely depends on clinical assessment. The standard way of doing this is by observing how the individual fits the criteria for autism listed in gold standard manuals like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).

Scientists argue the criteria we use for diagnosing autism may need revision

Without clear and effective biological tests for autism based on genes, brain or blood measurements, diagnosis today still largely depends on clinical assessment. The standard way of doing this is by observing how the individual fits the criteria for autism listed in gold standard manuals like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).

Scientists argue the criteria we use for diagnosing autism may need revision

Without clear and effective biological tests for autism based on genes, brain or blood measurements, diagnosis today still largely depends on clinical assessment. The standard way of doing this is by observing how the individual fits the criteria for autism listed in gold standard manuals like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).

Scientists argue the criteria we use for diagnosing autism may need revision

Without clear and effective biological tests for autism based on genes, brain or blood measurements, diagnosis today still largely depends on clinical assessment. The standard way of doing this is by observing how the individual fits the criteria for autism listed in gold standard manuals like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).

Scientists argue the criteria we use for diagnosing autism may need revision

Without clear and effective biological tests for autism based on genes, brain or blood measurements, diagnosis today still largely depends on clinical assessment. The standard way of doing this is by observing how the individual fits the criteria for autism listed in gold standard manuals like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).

Scientists argue the criteria we use for diagnosing autism may need revision

Without clear and effective biological tests for autism based on genes, brain or blood measurements, diagnosis today still largely depends on clinical assessment. The standard way of doing this is by observing how the individual fits the criteria for autism listed in gold standard manuals like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).

Scientists argue the criteria we use for diagnosing autism may need revision

Without clear and effective biological tests for autism based on genes, brain or blood measurements, diagnosis today still largely depends on clinical assessment. The standard way of doing this is by observing how the individual fits the criteria for autism listed in gold standard manuals like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).

Scientists argue the criteria we use for diagnosing autism may need revision

Without clear and effective biological tests for autism based on genes, brain or blood measurements, diagnosis today still largely depends on clinical assessment. The standard way of doing this is by observing how the individual fits the criteria for autism listed in gold standard manuals like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).

96 Global Health NOW: COVID-19 Research Canceled; Chikungunya Vaccines En Route to R茅union; and DOGE Cuts Harm Vulnerable Vets March 26, 2025 Colorized scanning electron micrograph of an apoptotic cell (blue) infected with SARS-COV-2 virus particles (green), isolated from a patient sample. NIH/NAID/IMAGE.FR/BSIP/Universal Images Group via Getty COVID-19 Research Canceled
The NIH and CDC have begun widespread terminations of grants related to COVID-19 research and public health outreach, saying 鈥渢he grant funds are no longer necessary,鈥� per an internal NIH document, . 

The large-scale grant terminations, amounting to billions, are unprecedented and 鈥渄angerous for future pandemic preparedness,鈥� said virologist Jason McLellan at the University of Texas, Austin, who was leading one of the canceled projects. 

• The virus has killed 7 million+ people globally, including 1.2+ million people in the U.S. Hundreds of people still die , and millions suffer debilitating long COVID symptoms. 

On the chopping block, :

• A program designing antiviral drugs for a range of pandemic-potential viruses. 


• Research to develop improved COVID-19 vaccines and to address long COVID.


• At least two set up to study virus transmission and immune response.

Cuts to health departments: Meanwhile, the CDC is axing ~$11 billion in COVID-related funding for health departments, 鈥攚ith HHS communications chief Andrew Nixon calling COVID a 鈥渘on-existent pandemic that Americans moved on from years ago.鈥�

• The funds were largely being used for testing, surveillance, vaccination, modernizing disease data systems, and addressing disparities.

Related: Vaccination cuts the risk of long COVID 27%, review suggests 鈥� GLOBAL HEALTH VOICES The Latest One-Liners   Deaths of children under 5 and stillbirths declined globally in 2023, to 4.8 million and ~1.9 million, respectively, continuing a trend of decreases since 2000; but progress has slowed in recent years鈥攁 pattern that experts worry new global funding cuts may exacerbate.

UK parenting charities and support groups are criticizing new issued in the British Journal of Sports Medicine, which recommended exercise and reduced screen time at night to improve physical and mental health; the parents鈥� groups say the guidance is 鈥渨ildly optimistic鈥� and could become 鈥渁nother stick to beat new mums with.鈥�

Healthy aging has been linked to a midlife diet rich in plant-based foods and low intake of ultra-processed foods, per a published in Nature Medicine that found that such a diet leads to higher likelihood of reaching age 70 without chronic disease. Thanks for the tip, Xiaodong Cai!

New FDA and NIH leaders have been confirmed by the U.S. Senate; Marty Makary will lead the FDA, while Jay Bhattacharya will head the NIH; both gained prominence for criticizing the U.S. COVID-19 response, and both were confirmed along party lines. Trump Administration News Researchers in limbo as Columbia bows to Trump鈥檚 demands in bid to restore $400M federal funding 鈥�

Vaccine skeptic hired to head federal study of immunizations and autism 鈥�

5 high-level officials leave CDC 鈥�

Remedy Supported by Kennedy Leaves Some Measles Patients More Ill 鈥�

FDA commissioner's abortion pill minefield 鈥� CHIKUNGUNYA OUTBREAK Vaccines En Route to R茅union  
Chikungunya vaccines are being rushed to France鈥檚 R茅union island in the Indian Ocean, where an outbreak has killed two, hospitalized dozens, and infected thousands of people over the last few weeks.
 
40,000 doses of Ixchiq, a Valneva-produced vaccine, will be aimed at the most vulnerable鈥攊ncluding those ages 65+, with severe comorbidities, or working in vector control.

• Chikungunya, spread by Aedes aegypti mosquitoes, is rarely fatal but causes symptoms including fever, headaches, and debilitating joint pain.


• No specific antibody treatments exist, but the vaccine is highly effective at preventing infection.

Climate connection? Cyclones, like the one that hit R茅union late last month, can leave standing water that increases populations of outbreak-fueling mosquitoes.  

GLOBAL HEALTH VOICES MENTAL HEALTH DOGE Cuts Harm Vulnerable Vets
Veterans鈥� mental health services are in disarray amid sweeping changes ordered by President Trump and implemented by Elon Musk鈥檚 Department of Government Efficiency.

Significant shifts: Thousands of mental health providers, including many fully remote employees, must work full-time from federal office space that often cannot accommodate their numbers or ensure patient privacy. 

• Clinicians say the changes, as well as the layoffs of ~2,000 probationary employees, will degrade mental health treatment at the Department of Veterans Affairs, which was already experiencing severe staffing shortages. 

Some providers predict a mass exodus of specialists, like psychiatrists and psychologists. They also expect wait times to increase, and veterans to seek treatment outside the agency鈥攐r withdraw from treatment altogether.

OPPORTUNITY QUICK HITS Thousands of women and girls in the West Bank exposed to gender based violence 鈥�

Guillain鈥揃arr茅 syndrome outbreak in Pune: a health emergency 鈥�

The toxic storm brewing in Soweto鈥檚 Snake Park 鈥�

Botswana reports surge in malaria cases 鈥�

Navigating US global health aid cuts: What can past donor exits teach us? 鈥�

鈥楲ife and death鈥�: Beshear vetoes GOP 鈥榗larification鈥� of Kentucky鈥檚 abortion ban 鈥�

Can generative AI tackle global health problems? 鈥�

As opposition to fluoride grows, rural America risks a new surge of tooth decay 鈥�

The Liverpool team preparing for future pandemics 鈥�

鈥楬uge brown eyes鈥�: Irish farmer comes up with alpaca therapy for elderly patients, special-needs children 鈥� Issue No. 2697
Global Health NOW is an initiative of Johns Hopkins Bloomberg School of Public Health.

Contributors include Brian W. Simpson, MPH, Dayna Kerecman Myers, Annalies Winny, Morgan Coulson, Kate Belz, Melissa Hartman, Jackie Powder, and Rin Swann. Write us: dkerecm1@jhu.edu, like us on and follow us on Instagram and X .

Please send the Global Health NOW free sign-up link to friends and colleagues:

Want to change how you receive these emails? You can or . -->



 
  Copyright 2025 Johns Hopkins Bloomberg School of Public Health. All Rights Reserved. Views and opinions expressed in Global Health NOW do not necessarily reflect those of the Johns Hopkins Bloomberg School of Public Health or Johns Hopkins University.


Want to change how you receive these emails?
You can or .

Childhood stunting from malnutrition is a global but preventable problem if adequate investment can be found, the UN World Food Programme (WFP) said on Wednesday, amid chronic funding shortages that threaten essential feeding programmes.

Montreal, March 26, 2025 鈥� 黑料网鈥檚 DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based therapies for cancer and rare genetic diseases. The awards were initially announced at the D2R Research Symposium on March 13, 2025.

Montreal, March 26, 2025 鈥� 黑料网鈥檚 DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based therapies for cancer and rare genetic diseases. The awards were initially announced at the D2R Research Symposium on March 13, 2025.

Montreal, March 26, 2025 鈥� 黑料网鈥檚 DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based therapies for cancer and rare genetic diseases. The awards were initially announced at the D2R Research Symposium on March 13, 2025.

Montreal, March 26, 2025 鈥� 黑料网鈥檚 DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based therapies for cancer and rare genetic diseases. The awards were initially announced at the D2R Research Symposium on March 13, 2025.

Montreal, March 26, 2025 鈥� 黑料网鈥檚 DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based therapies for cancer and rare genetic diseases. The awards were initially announced at the D2R Research Symposium on March 13, 2025.

Montreal, March 26, 2025 鈥� 黑料网鈥檚 DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based therapies for cancer and rare genetic diseases. The awards were initially announced at the D2R Research Symposium on March 13, 2025.

Montreal, March 26, 2025 鈥� 黑料网鈥檚 DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based therapies for cancer and rare genetic diseases. The awards were initially announced at the D2R Research Symposium on March 13, 2025.

Montreal, March 26, 2025 鈥� 黑料网鈥檚 DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based therapies for cancer and rare genetic diseases. The awards were initially announced at the D2R Research Symposium on March 13, 2025.

Montreal, March 26, 2025 鈥� 黑料网鈥檚 DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based therapies for cancer and rare genetic diseases. The awards were initially announced at the D2R Research Symposium on March 13, 2025.